0001104659-15-075341.txt : 20151103
0001104659-15-075341.hdr.sgml : 20151103
20151103171039
ACCESSION NUMBER: 0001104659-15-075341
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151030
FILED AS OF DATE: 20151103
DATE AS OF CHANGE: 20151103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ophthotech Corp.
CENTRAL INDEX KEY: 0001410939
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE PENN PLAZA
STREET 2: 19TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10119
BUSINESS PHONE: 212-845-8200
MAIL ADDRESS:
STREET 1: ONE PENN PLAZA
STREET 2: 19TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GUYER DAVID R
CENTRAL INDEX KEY: 0001277476
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36080
FILM NUMBER: 151194542
MAIL ADDRESS:
STREET 1: ONE PENN PLAZA, 19TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10119
4
1
a4.xml
4
X0306
4
2015-10-30
0
0001410939
Ophthotech Corp.
OPHT
0001277476
GUYER DAVID R
C/O OPHTHOTECH CORPORATION
ONE PENN PLAZA, 19TH FLOOR
NEW YORK
NY
10119
1
1
0
0
Chief Executive Officer
Common Stock
2015-10-30
4
M
0
18582
10.03
A
48492
D
Common Stock
2015-10-30
4
S
0
18482
49.88
D
30010
D
Common Stock
2015-10-30
4
S
0
100
50.27
D
29910
D
Stock Option (Right To Buy)
10.03
2015-10-30
4
M
0
18582
0.00
A
2023-04-25
Common Stock
18582
224666
D
The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2013.
These shares were disposed of in multiple transactions on October 30, 2015 at actual sales prices ranging from $49.27 to $50.24 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
This option was granted on April 26, 2013 and vests as to 1/48 of the shares underlying such option each month until April 2017.
/s/ Justin Vogel, as Attorney-in-Fact for David Guyer
2015-11-03